Fuelling proliferation: how transporters control metabolism in development and cancer

Fuelling proliferation: how transporters control metabolism in development and cancer

Research Question and Applicant Fit

Do cancer cells regain a growth-supporting state by reusing metabolic programmes from early development, and what role do membrane transporters play? The project examines mechanism rather than clinical efficacy. The strongest signal is the fit between Fets transporters/cancer metabolism, Percharde chromatin/development and LMS metabolomics/bioinformatics infrastructure. The main uncertainty is the first-year focus: public material does not name the priority transporter, cancer model, embryonic-stem-cell comparison or in vivo model.

The saved LMS 2027 studentship page lists this project with the supervisor line Louise Fets (LMS) & Michelle Percharde (LMS); the official application form also lists the project in the 2026-27 application round (LMS recruitment page, application form PDF, project document). The saved recruitment page gives 18 November 2026 at 9:00; its application form specifies 9am UK time. Funding is valuable for selected candidates because LMS states four years of £26,500 annual tax-free stipend, full tuition-fee coverage, research consumables and visa costs for overseas students (LMS recruitment page). This is still a competitive studentship, so eligibility to apply is separate from being awarded funding.

Research Problem and Doctoral Work

What Is Unsolved and Why It Matters

Membrane transporters regulate nutrient and ion uptake, waste release and the movement of metabolites between organelles. In development, timed changes in transporter expression are linked to growth, proliferation and epigenetic state. The project asks whether cancer cells co-opt these developmental programmes to support proliferation in difficult microenvironments. Shared expression alone would not establish that the same programme has the same functional role in both settings.

The central distinction is between changes in metabolite transport, changes in cell state and other processes supporting proliferation. The priority transporter, cancer model, embryonic-stem-cell comparison and later in vivo model are not named in the saved advert. This is a mechanistic research question, not evidence that a clinical treatment or universal cancer mechanism has been established.

Doctoral Tasks, Methods and Potential Outputs

The recruitment identifies three linked research tasks: identify transporters shared by embryonic-stem-cell and cancer metabolic programmes; determine how those transporters reshape metabolism and cell state; and test their importance for tumour growth, with in vivo work planned for later in the project. This sequence of questions is more specific than an open-ended screen, but the student's starting system and feasible first-year scope remain to be agreed.

The advertised training covers cancer and embryonic-stem-cell culture, molecular biology, microscopy, mass-spectrometry-based metabolomics and bioinformatics. LMS research infrastructure and shared metabolomics, bioinformatics and whole-animal facilities are relevant support signals, not a guarantee of personal access or of every model already being ready (LMS research overview, metabolomics facility, bioinformatics facility, whole-animal facility).

Supervisor and Lab Assessment

Supervisor Research Directions

The supervisor signal is project-specific. Dr Louise Fets and Dr Michelle Percharde connect the advertised theme to established LMS research directions rather than to a generic topic label (lead/group source, collaborating supervisor or group source). The advantage is proximity to active methods and infrastructure. The risk is that public information does not yet specify the exact first-year system and daily supervision split.

Relevant Research Evidence

Multimodal imaging reveals a lysosomal drug reservoir that drives heterogeneous distribution of PARP inhibitors (2025)

The retained preprint maps heterogeneous subcellular drug accumulation and lysosomal reservoir behaviour. It supports expertise connecting transport, imaging and drug distribution, rather than proving developmental metabolic reactivation. Its PARP-inhibitor focus and preprint status limit the inference; it is not clinical efficacy evidence, and the retained version does not establish whether a later publication exists. Paper.

Membrane transporters in cell physiology, cancer metabolism and drug response (2023)

This review synthesises how transporters shape physiology, cancer metabolism and drug response. It is a conceptual foundation for the project, not an original dataset or a demonstrated result of the proposed doctorate. Review.

MOG analogues to explore the MCT2 pharmacophore, alpha-ketoglutarate biology and cellular effects of N-oxalylglycine (2022)

This original uses transporter/metabolite chemistry to investigate MCT2 and alpha-ketoglutarate-linked biology. It supports experience with transporter-mediated mechanisms but does not itself establish developmental reactivation or cancer stemness. Paper.

Dynamic enlargement and mobilization of lipid droplets in pluripotent cells coordinate morphogenesis during mouse peri-implantation development (2022)

This original connects lipid metabolism and pluripotent-cell development around peri-implantation morphogenesis. It supports the developmental-metabolism side of the collaboration, while lipid-droplet biology is distinct from evidence for a particular transporter programme. Paper.

Lab, Resources, and Collaboration Environment

LMS is a compact institute setting, which can be better for this type of project than a loosely connected departmental structure. The application form asks applicants to write about selected projects and skills, and it explicitly names broad skill categories such as screening, model organisms, molecular biology, gene editing, bioinformatics, AI, quantitative biology, imaging, genomics and mass spectrometry (application form PDF). A strong application should therefore show both motivation and method readiness.

School, Programme, and Field Context

LMS is listed by UKRI as an MRC institute, and LMS PhD students are enrolled through Imperial College London’s Faculty of Medicine (UKRI MRC list, LMS PhD study page). Imperial adds recognised university signal and external ranking visibility (QS Imperial profile).

The current website department field reads “Postgraduate Studies”; its formal mapping to the Imperial Faculty of Medicine registration route is unconfirmed.

The two laboratories combine drug transport/tumour metabolism with chromatin/development. Training across cell biology, metabolomics, imaging and bioinformatics is part of that research setting, not a requirement to arrive with every technique. The saved recruitment does not specify the full timetable of taught modules, progression reviews or rotations; clarify how training, supervision and later-stage work fit within the four-year award.

Funding, Application, and Living Cost

For successful studentship awardees, the funding package is strong: four years, £26,500 per year tax-free stipend, full tuition-fee coverage, research consumables and overseas visa costs (LMS recruitment page). Chinese applicants are eligible to apply under the all-nationalities wording, but there is no personal award guarantee. The stated tuition coverage is part of the successful award. Before accepting, confirm the individual award/payment arrangements, CAS wording and whether overseas visa costs are paid or reimbursed; IHS and dependant costs remain to be clarified.

London remains expensive. UKVI financial-evidence rules and Imperial official living-cost estimates make the CAS/funding wording practically important, especially for deposits, early rent and maintenance evidence (UKVI financial evidence, Imperial living-cost estimates). The stipend is strong for a UK PhD, but first-month cash flow can still be tight.

Applicant Fit and Preparation

Academic Requirements and Research Fit

The existing LMS admission information requires an obtained or expected first-class or upper-second-class degree or equivalent in a relevant scientific subject. A relevant master’s is preferred, and equivalent research experience totalling at least one year may be considered. The examples below indicate fit rather than additional requirements to know every method.

Relevant backgrounds include cell biology or biochemistry with metabolism experience; molecular or cancer biology with an interest in developmental comparisons; and bioinformatics combined with biological experimental experience. Metabolomics and cell-state interpretation connect these areas. The application should show a project-specific research logic, not only enthusiasm. Imperial English-language requirements should be checked by applicants whose first language is not English (Imperial English requirements).

Preferred Experience and Suggested Preparation

Useful preparation: read the official project document, compare two relevant studies from the evidence above, prepare a short methods table separating skills already held from skills to learn, and write one concise paragraph on how to validate the central mechanism without overclaiming outcomes. The project is less suitable for applicants seeking direct clinical-trial or therapy-efficacy work, purely computational applicants without wet-lab or biological-mechanism evidence, candidates uncomfortable with in vivo work later in the project.

Career and Transferable Skills

The field context is favourable for applicants who can combine experimental biology with data-rich analysis: UK life-sciences sources continue to emphasize data, genomics, AI, biotechnology and translational skill needs (UK life-sciences jobs plan, Skills England life-sciences assessment, UKRI data-driven biology).

The project can develop critical interpretation across transporter expression, metabolic measurements and cellular phenotypes. These skills may support academic, biotechnology or cancer-metabolism research, but neither institute membership nor a mechanistic result guarantees a clinical product, qualification or job. A useful doctoral contribution could be a clear account of where developmental and cancer programmes differ, rather than confirmation of the initial hypothesis.

Next Actions and Questions to Verify

Before Applying

The retained form requires a completed electronic application sent to students@lms.mrc.ac.uk and two academic referees who send their references directly. Registering interest does not count. The retained intended intake is 4 October 2027; the reference arrival deadline and personal start still need confirmation.

1. Confirm in the application portal that the deadline follows the application form wording: 18 November 2026, 9am UK time.
2. Confirm full international-fee coverage and overseas visa-cost mechanism for a Chinese awardee.
3. Confirm that the linked project document is the final project text for the round.

At Interview

1. Ask which system, target set, candidate set or assay anchors year 1.
2. Ask how daily supervision works between Dr Louise Fets and Dr Michelle Percharde.
3. Ask which facility or approval process is expected to be the bottleneck.

Before Accepting an Offer

1. Request written stipend schedule, fee coverage, CAS wording and visa-cost support details.
2. Confirm any ethics, GM, animal, containment, stem-cell or organismal-screening requirements before committing.

Evidence and Sources

The saved LMS 2026–27 recruitment material and application form identify this project and state a deadline of 18 November 2026 at 9:00 am UK time. They do not establish whether applications are currently being accepted. The inherited research evidence comprises one retained preprint, one review and two 2022 original studies. The available texts do not establish full ordered bylines, detailed individual contributions or complete full-text/supplement access for each; no further paper assessment is claimed.

• Official recruitment and application: LMS 4-year PhD studentships, LMS application form PDF, project document.
• Institution and programme: LMS PhD study page, UKRI MRC institute list, LMS research overview, QS Imperial profile.
• Supervisor/lab and papers: lead profile, group/supervisor source, paper 1, paper 2, paper 3, paper 4.
• Cost, visa and market context: UKVI financial evidence, Imperial living-cost estimates, UK life-sciences jobs plan, Skills England life-sciences assessment, UKRI data-driven biology.
• Current LMS 2026–27 application form: 9am UK time.